United Kingdom
Chiltern International, founded in 1982 and headquartered in the United Kingdom, operates in the Biopharma, Medical Devices, and Pharmaceutical industries. Under the slogan "Clinical development, scientific services," the company has carved out a reputation for delivering specialized clinical development and scientific services.
The company's growth trajectory culminated in a strategic acquisition by LabCorp on 01 July 2017. This acquisition is indicative of Chiltern International's value in delivering innovative solutions to its clients. The blend of internal expertise and strategic partnerships positions Chiltern as a significant player in the life sciences sector, offering robust opportunities for comprehensive clinical development solutions.
For potential investors, Chiltern International represents a mature, established entity in a high-growth industry segment, further validated through its successful acquisition by a major player such as LabCorp.
